logo
CONSUMING TREE NUTS AS SNACKS COULD AID IN PREVENTING THE DEVELOPMENT OF EXCESS BODY FAT AND CARDIOMETABOLIC DISEASE IN MILLENIALS

CONSUMING TREE NUTS AS SNACKS COULD AID IN PREVENTING THE DEVELOPMENT OF EXCESS BODY FAT AND CARDIOMETABOLIC DISEASE IN MILLENIALS

New Findings Published in Clinical Nutrition in Partnership with The International Tree Nut Council Nutrition Research & Education Foundation
DAVIS, Calif., March 12, 2025 /PRNewswire/ -- In a recent study published online in the journal, Clinical Nutrition 1, replacing high-carbohydrate snacks with tree nuts resulted in more favorable dietary, plasma and adipose tissue fatty acid profiles that could aid in preventing the development of excess body fat and cardiometabolic disease states, including metabolic syndrome.
Researchers at Vanderbilt University Medical Center conducted a randomized, parallel arm, dietary intervention study with 84 men and women, ages 22-36, most of whom were either overweight or obese (BMI 24.5 to 34.9 kg/m2) and had at least one metabolic syndrome risk factor at baseline (abdominal obesity, elevated triglycerides, low HDL cholesterol, high blood pressure, or elevated levels of blood glucose). Participants consumed about an ounce (33.5g) of mixed unsalted tree nuts (almonds, Brazil nuts, cashews, hazelnuts, macadamias, pecans, pine nuts, pistachios and walnuts) or one ounce of a carbohydrate-rich snack twice daily. Both snacks provided the same number of calories, protein, fiber, and sodium and were part of a 7-day weight maintenance menu that repeated throughout the study duration of 16 weeks.
According to Principal Investigator, Heidi J. Silver, R.D., M.S., Ph.D., Research Professor of Medicine at Vanderbilt University Medical Center, replacing high-carbohydrate snacks with mixed tree nuts increased mono- and polyunsaturated fat intakes resulting in a 9-fold greater dietary unsaturated to saturated fat ratio. The tree nut snack group also had a significantly greater improvement in plasma fatty acid profiles, without requiring a reduction in calories or weight change. Moreover, positive changes in the expression of 13 genes in the abdominal subcutaneous adipose tissue were seen in the tree nut snack participants, but not significantly in those consuming the high-carbohydrate snack. These changes—all of which can impact the risk for developing metabolic syndrome—occurred in genes involved in lipolysis (helps the body break down fat for energy), glycemia, immune pathways and vulnerability to obesity.
Metabolic syndrome and its various risk factors, including high abdominal adiposity and blood glucose levels, are on the rise worldwide. Today one in five young adults in the US, aged 20 to 39, have metabolic syndrome. At the same time, the frequency of snacking has also risen. One in three young adults consume three or more snacks per day and those snacks are typically high in calories and carbohydrates, providing almost 25% of total daily calories.
'As we reported previously, substituting a high-carbohydrate snack with a mix of tree nuts reduced visceral fat and waist circumference, as well as overall risk of metabolic syndrome, in both male and female young adults with one or more metabolic syndrome risk factor,' stated Dr. Silver. 'These new findings further support substituting tree nuts for daily snacks as an effective strategy to minimize risk for chronic cardiometabolic disease.'
A growing body of research has shown the beneficial effects of tree nuts in helping to reduce the risk of several chronic diseases including overweight/obesity, diabetes, and heart disease. 'In 2003, the FDA (in its qualified health claim for nuts and heart disease) recommended that people eat 1.5 ounces of nuts per day—well above current consumption levels,' stated Maureen Ternus, M.S., R.D.N, Executive Director of the International Tree Nut Council Nutrition Research & Education Foundation (INC NREF). 'We should be encouraging people—especially those Millennials at risk for metabolic syndrome—to get their handful of nuts every day.'
The International Tree Nut Council Nutrition Research & Education Foundation (INC NREF) is a non-profit, non-governmental organization dedicated to supporting nutrition research and education for consumers and health professionals throughout the world. Members include those associations and organizations that represent the nine tree nuts (almonds, Brazil nuts, cashews, hazelnuts, macadamias, pecans, pine nuts, pistachios and walnuts). For more information, please visit our website at www.nuthealth.org.
1 Widmer, A., K. Lillegard, K. Wood, M. Robles, R. Fan, F. Ye, J.R. Koethe, H.J. Silver, 2025. Consumption of Tree Nuts as Snacks Stimulates Changes in Plasma Fatty Acid Profiles and Adipose Tissue Gene Expression in Young Adults at Risk for Metabolic Syndrome. Clinical Nutrition.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Michelle Monaghan Champions Skin Health in New Awareness Campaign
Michelle Monaghan Champions Skin Health in New Awareness Campaign

Yahoo

timean hour ago

  • Yahoo

Michelle Monaghan Champions Skin Health in New Awareness Campaign

NEW YORK, May 30, 2025 /PRNewswire/ -- Healthy skin is more than surface-level, it's a key part of our overall well-being. That's why Mediaplanet is proud to launch its "Skin Health" campaign, aimed at empowering individuals to take charge of their skin through education, prevention, and smart skincare choices. From early detection to everyday sun protection, this campaign emphasizes that maintaining healthy skin is a lifelong commitment. Skin is our body's largest organ, yet it's often overlooked when it comes to proactive care. This campaign is designed to change that by delivering expert guidance, highlighting innovative dermatological advances, and sharing practical tips for every age and skin type. Whether you're managing a chronic condition or simply want to build better daily habits, the "Skin Health" campaign offers resources to help you prioritize long-term skin wellness. Featuring cover story Michelle Monaghan, the campaign brings a personal and powerful voice to the conversation. The award-winning actress opens up about her experience with skin cancer, how motherhood reshaped her view on sun safety, and the importance of early detection. In her exclusive interview, Monaghan shares the simple yet critical habits she relies on — like daily sunscreen use and routine skin checks — while encouraging others to take their skin health seriously. The print component of "Skin Health" is distributed in today's edition of USA Today. The digital component is distributed nationally, through a vast social media strategy, and across a network of top news sites and partner outlets. To explore the digital version of the campaign, visit: This campaign was made possible with the support of Michelle Monaghan, Jennie Garth, Dr. Charles, MD, Dr. Jenny Liu, M.D., FAAD, Dr. Lindsey Zubritsky, M.D., FAAD, Dr. Mamina Turegano, M.D., FAAD, the Skin Cancer Foundation, the American Society for Dermatologic Surgery, the Society for Pediatric Dermatology, the Society of Cosmetic Chemists, the Coalition of Skin Diseases, the National Foundation for Ectodermal Dysplasias and features paid content from the Melanoma Research Foundation, Castle Biosciences, GentleCure & Sciton. View original content to download multimedia: SOURCE Mediaplanet Sign in to access your portfolio

Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025

Yahoo

time2 hours ago

  • Yahoo

Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025

WARSAW, Ind., May 30, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2025. The cash dividend of $0.24 per share is payable on or about July 31, 2025 to stockholders of record as of the close of business on June 26, 2025. About Zimmer Biomet Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit or follow on LinkedIn at or X / Twitter at Media Investors Heather Zoumas-Lubeski David DeMartino 445-248-0577 646-531-6115 Weiner 908-591-6955 View original content to download multimedia: SOURCE Zimmer Biomet Holdings, Inc.

National Awareness Campaign Highlighting the Future of Cancer Care
National Awareness Campaign Highlighting the Future of Cancer Care

Yahoo

time2 hours ago

  • Yahoo

National Awareness Campaign Highlighting the Future of Cancer Care

NEW YORK, May 30, 2025 /PRNewswire/ -- Cancer care is evolving and with it, the stories of those impacted are reshaping how we understand healing, advocacy, and support. Mediaplanet is proud to launch the Future of Cancer Care, a national campaign focused on raising awareness around advancements in cancer treatment, survivorship, and personalized care. This campaign aims to empower patients, caregivers, and providers with knowledge, compassion, and hope. From cutting-edge treatments to the critical importance of early detection, the Future of Cancer Care highlights innovations that are changing outcomes and improving lives. Through expert-driven content, survivor stories, and actionable guidance, the campaign brings much-needed visibility to the full cancer care continuum—from diagnosis through recovery and beyond. Featuring cover story Jenna Fischer, the campaign centers on courage, vulnerability, and community. The actress opens up about her own journey with breast cancer, from diagnosis to remission and everything in between. In a candid interview, Fischer discusses how she navigated treatment while continuing to work, the holistic routines that supported her recovery, and how community became her lifeline. She now uses her platform to raise awareness, mentor other women facing a diagnosis, and advocate for more flexible, compassionate work environments for cancer patients. Her story underscores the campaign's mission: to inspire proactive care, empower patient voices, and humanize the evolving landscape of cancer treatment. The print component of "Future of Cancer Care" will be distributed in of USA Today. The digital component is distributed nationally, through a vast social media strategy, and across a network of top news sites and partner outlets. To explore the digital version of the campaign, visit: This campaign was made possible with the support of Jenna Fischer, the American Society of Clinical Oncology, the Association of Cancer Care Centers, Imerman Angels, the Personalized Medicine Coalition, the National Comprehensive Cancer Network and features paid content from Agilent, Galapagos, Eli Lilly and Company, BostonGene, Novocure & Qure AI, Summit Therapeutics & Accessia Health. View original content to download multimedia: SOURCE Mediaplanet Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store